PATENT ASSIGNEE'S COUNTRY | USA |
UPDATE | 01.00 |
PATENT ASSIGNEE | SangStat Medical (Fremont; Ca) |
PATENT CLAIMS |
Method of inhibiting T cell activity in graft vs. host disease - Contact T cells with formulation comprising D-glucuronic beta (1-3) N-acetyl-D-glucosamine polymers of 2-80 disa ccharide subunits in length |
PATENT PHOTOCOPY | Available on request |
Want more information ? Interested in the hidden information ? Click here and do your request. |